On May 18, at the 2025 American Thoracic Society (ATS) International Conference, updated findings from a post hoc analysis poster presentation of the Phase III MATINEE trial (NCT04133909 ...

A symposium at the 2023 American Thoracic Society (ATS) International Conference featured research on predictors of chronic obstructive pulmonary disease (COPD) occurrence and disease progression.

On 18 May 2025, at the American Thoracic Society International Conference, held in San Francisco, California, post hoc findings from the Phase IIa COURSE trial (NCT04039113) shed light on the ...

Summary. The 2024 International Conference of the American Thoracic Society (ATS) in San Diego highlighted significant advancements in COPD research, including promising results for PDE3/PDE4 ...

A range of posters presented at the 2023 American Thoracic Society (ATS) International Conference highlighted a plethora of risk factors for pulmonary conditions in adulthood outside of tobacco ...

COPD accounts for the majority of chronic lower respiratory mortality in the US at 150,000 deaths per year, and data suggests patients with COPD are, on average, 50 times more likely to die from ...

Both nicotine cravings and levels of cotinine significantly fell in adults treated with cytisinicline vs. placebo who failed ...

The Jacobs School of Medicine and Biomedical Sciences had a strong showing at this year’s American Thoracic Society (ATS) 2025 annual conference in San Francisco in May, where a team of researchers ...

Amgen and AstraZeneca say Tezspire shows proof of concept in COPD trial reported at ATS2024, despite missing primary endpoint. Skip to main ... (ATS) congress – showed that the ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease ... Annals of the American Thoracic Society (2024). DOI: 10.1513/AnnalsATS.202408-864IP ...

Home oxygen therapy for adults with COPD and ILD: New ATS clinical practice guideline. Nov 18, 2020. Two-fifths of US seniors with COPD have poor access to pulmonary rehabilitation.

Stephanie A. Christenson, MD, MAS, discusses advancements in COPD research to be presented at ATS 2024. Updates from clinical trials, particularly regarding biologics and biomarker data related to ...